Search results
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 4 days agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 6 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 6 days agoThe study is evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 6 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 2 days agoMerck currently has one of the best-selling therapies in the world in its portfolio. That is none...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 6 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 6 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 5 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 6 days ago“We're undergoing a pretty substantial transformation from a strategy that was focusing on...